NCT00670033View on ClinicalTrials.gov

Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Ocular HypertensionOpen-angle Glaucoma
Interventions
DRUG

Travoprost ophthalmic solution (new formulation)

DRUG

Travoprost ophthalmic solution, 0.004%

DRUG

Vehicle

Inactive ingredients used as a placebo

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY